Weight-Based Chemotherapy Dosing in Obese Patients With Cancer: Back to the Future

被引:20
作者
Lyman, Gary H. [1 ,2 ]
机构
[1] Duke Univ, Comparat Effect & Outcomes Res Oncol, Durham, NC 27706 USA
[2] Duke Canc Inst, Durham, NC USA
关键词
D O I
10.1200/JOP.2012.000606
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E62 / E64
页数:3
相关论文
共 34 条
[31]   The Norton-Simon hypothesis: designing more effective and less toxic chemotherapeutic regimens [J].
Simon, Richard ;
Norton, Larry .
NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08) :406-407
[32]  
SKIPPER HE, 1971, CANCER-AM CANCER SOC, V28, P1479, DOI 10.1002/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO
[33]  
2-M
[34]   Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese [J].
Sparreboom, Alex ;
Wolff, Antonio C. ;
Mathijssen, Ron H. J. ;
Chatelut, Etienne ;
Rowinsky, Eric K. ;
Verweij, Jaap ;
Baker, Sharyn D. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) :4707-4713